Literature DB >> 4070905

Importance of reinfection in the pathogenesis of trachoma.

J T Grayston, S P Wang, L J Yeh, C C Kuo.   

Abstract

The authors' epidemiologic studies of trachoma on Taiwan and experimental monkey eye infections with and without Chlamydia trachomatis immunization are reviewed for the data they provide on the pathogenesis of trachoma. These studies indicate that trachoma is an immunopathologic disease in which the more severe progressive trachoma infections with pannus and scar formation occur only after reinfection. This hypothesis is supported by a 10-year study of 32 family households that were followed with repeated clinical and laboratory observations. Although most cases of active trachoma healed spontaneously, there were 26 persons in nine families who developed clinical and laboratory evidence of 29 episodes of new trachoma eye infection. On the basis of the clinical disease, its persistence, and the laboratory findings, these 29 new infections could be divided into 10 primary, nine secondary, and 10 tertiary infections. Details of the different stages of infection leading to chronic trachoma are presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070905     DOI: 10.1093/clinids/7.6.717

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  88 in total

Review 1.  Eradication of trachoma worldwide.

Authors:  D Mabey; R Bailey
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Heat shock protein 60 is the major antigen which stimulates delayed-type hypersensitivity reaction in the macaque model of Chlamydia trachomatis salpingitis.

Authors:  Anne B Lichtenwalner; Dorothy L Patton; Wesley C Van Voorhis; Yvonne T Cosgrove Sweeney; Cho-Chou Kuo
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

3.  Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Authors:  D M Magee; J G Smith; C A Bleicker; C J Carter; L F Bonewald; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.

Authors:  Anthony W Solomon; Zeena Mohammed; Patrick A Massae; John F Shao; Allen Foster; David C W Mabey; Rosanna W Peeling
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

6.  Anatomical factors influencing development of trichiasis and entropion in trachoma.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

Review 7.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  An in vitro model for immune control of chlamydial growth in polarized epithelial cells.

Authors:  J U Igietseme; P B Wyrick; D Goyeau; R G Rank
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting.

Authors:  H D Caldwell; S Stewart; S Johnson; H Taylor
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.